Tumor anorexia: Effects on neuropeptide Y and monoamines in paraventricular nucleus

Peptides

Volumn 25, Issue 2, 2004, Pages 261-266

  Meguid, Michael M ^a   Ramos, Eduardo J B ^a   Laviano, Alessandro ^b   Varma, Madhu ^a   Sato, Tomoi ^a   Chen, Chung ^a   Qi, Yong ^a   Das, Undurti N ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anorexia; Dopamine; Food intake; Hypothalamus; NPY; Serotonin; Tumor bearing

Indexed keywords

MONOAMINE DERIVATIVE; NEUROPEPTIDE Y; SEROTONIN;

ANIMAL TISSUE; ANOREXIA; ARTICLE; ASSOCIATION; CANCER SURGERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FOOD; HYPOTHALAMUS; INTERMETHOD COMPARISON; MOLECULAR MECHANICS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RAT; SEROTONINERGIC SYSTEM; THALAMUS MIDLINE NUCLEUS; TUMOR;

ANIMALS; ANOREXIA; DOPAMINE; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; SARCOMA, EXPERIMENTAL; SEROTONIN;

EID: 1942516505     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.01.012     Document Type: Article

References (35)

1. Bina K.G., Cincotta A.H. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology. 71:2000;68-78.
2. Blaha V., Yang Z.J., Meguid M.M., Chai J.K., Oler A., Zadak Z. Ventromedial nucleus of hypothalamus is related to the development of cancer-induced anorexia: in vivo microdialysis study. Acta Medica. (Hradec Kralove). 41:1998;3-11.
3. Chance W.T., Balasubramaniam A., Sheriff S., Fischer J.E. Possible role of neuropeptide Y in experimental cancer anorexia. Adv. Exp. Med. Biol. 354:1994;185-201.
4. Currie P.J., Coiro C.D., Niyomchai T., Lira A., Farahmmand F. Hypothalamic paraventricular 5-hydroxytryptamine: receptor specific inhibition of NPY-stimulated eating and energy metabolism. Pharmacol. Biochem. Behav. 71:2002;709-716.
5. Curzon G., Gibson E.L., Oluyomi A.O. Appetite suppression by commonly used drugs depends on 5-HT receptors but not 5-HT availability. TIPS. 18:1997;21-25.
6. Dryden S., Frankish H.M., Wang Q., Williams G. Neuropeptide Y and energy balance: one-way ahead from the treatment of obesity? Eur. J. Clin. Invest. 24:1994;293-308.
7. Dryden S., Wang Q., Frankish H.M., Pickavance L., Williams G. The serotonin (5-HT) antagonist metysergide increases neuropeptide Y (NPY) synthesis and secretion in the hypothalamus of the rat. Brain Res. 699:1995;12-18.
8. Fetissov S.O., Meguid M.M., Chen C., Miyata G. Synchronized release of dopamine and serotonin in the medial and lateral hypothalamus of rats. Neuroscience. 101:2000;657-663.
9. Gillard E.R., Dang D.Q., Stanley B.G. Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Res. 628:1993;128-136.
10. Heisle L.K., Cowley M.A., Tecott L.H., Fan W., Low M.J., Smart J.L.et al. Activation of central melanocortin pathways by fenfluramine. Science. 297:2002;609-611.
11. Hoebel B.G., Hernandez L., Schwartz D.H., Mark G.P., Hunter G.A. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann. NY Acad. Sci. 575:1989;171-191.
12. Kuo Y. Co-administration of dopamine d(1) and d(2) agonists additively decreases daily food intake. J. Biomed. Sci. 9:2002;126-132.
13. Laviano A., Meguid M.M., Yang Z.J., Gleason J.R., Cangiano C., Fanelli F.R. Cracking the riddle of cancer anorexia. Nutrition. 12:1996;706-710.
14. Li S., Pelletier G. The role of dopamine in the control of neuropeptide Y neurons in the rat arcuate nucleus. Neurosci. Lett. 69:1986;74-77.
15. Makarenko I.G., Meguid M.M., Gatto L., Chen C., Ugrumov M.V. Decreased NPY innervation of the hypothalamus nuclei in rats with cancer anorexia. Brain Res. 24(961):2003;100-108.
16. 1B) receptors in the normal rat hypothalamus. Neurosci. Lett. 328:2002;155-159.
17. Marks D.L., Butler A.A., Turner R., Brookhart G., Cone R.D. Differential role of melanocortin subtypes in cachexia. Endocrinology. 144:2003;1513-1523.
18. Martin-Inverson M.T., Dourish C.T. Role of D1 and D2 receptors subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology. 96:1988;370-374.
19. McCarthy H.D., McKibbin P.E., Perkins A.V., Linton E.A., Williams G. Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am. J. Physiol. 264:1993;E638-E643.
20. Meguid M.M., Kawashima Y., Campos A.C., Gelling P.D., Hill T.W., Chen T.Y.et al. Automated computerized rat eater meter: description and application. Physiol. Behav. 48:1990;759-763.
21. Meguid M.M., Laviano A., Rossi-Fanelli F. Food intake equals meal. size×meal number Appetite. 31:1998;404.
22. Meguid M.M., Yang Z.J., Laviano A. Meal size and number: relationship to dopamine levels in the ventromedial hypothalamic nucleus. Am. J. Physiol. 272:1997;R1925-R1930.
23. Miklya I., Knoll B., Knoll J. An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats. Life Sci. 72:2003;2923-2930.
24. Mohankumar P.S., Thyagarajan S., Quadri S.K. Interleukin-1 beta increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo. Brain Res. Bull. 31:1993;745-748.
25. Mohankumar S.M., Mohankumar P.S., Quadri S.K. Specificity of interleukin-1beta-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonist. Brain Res. Bull. 47:1998;29-34.
26. Orosco M., Gerozissis K., Rouch C., Meile M.J., Nicolaidis S. Hypothalamic monoamines and insulin in relation to feeding in the genetically obese Zucker rat as revealed by microdialysis. Obesity Res. 3:1995;655S-665S.
27. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59:1973;449-450.
28. Paxinos G, Watson C, editors. The rat brain in stereotaxic coordinates. New York: Academic Press; 1997.
29. Razos A., Palacios J.M. Quantitative auto radiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
30. Rogers P., McKibbin P.E., Williams G. Acute fenfluramine administration reduces neuropeptide Y concentration in specific hypothalamic regions of the rat: possible implications for the anorectic effect of fenfluramine. Peptides. 12:1997;251-255.
31. Sato T., Meguid M.M., Fetissov S.O., Chen C., Zhang L. Hypothalamic dopaminergic receptor expressions in anorexia of tumor bearing rats. Am. J. Physiol. Regul. Integrat. Comp. Physiol. 281:2001;R1907-R1916.
32. Schwartz M.W., Woods S.C., Porte D. Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 404:2000;661-671.
33. Stanley B.G., Magdalin W., Seirafi A., Thomas W.J., Leibowitz S.F. The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system (s). Brain Res. 604:1993;304-317.
34. Thorre K., Sarre S., Smolders I., Ebinger G., Michotte Y. Dopaminergic regulation of serotonin release in the substantia nigra of the freely moving rat using microdialysis. Brain Res. 796:1998;107-116.
35. Yang Z.J., Blaha V., Meguid M.M., Laviano A., Oler A., Zadak Z. Interleukin-1 alpha injection into ventromedial hypothalamic nucleus of normal rats depresses food intake and increases release of dopamine and serotonin. Pharmacol. Biochem. Behav. 62:1999;61-65.